Literature DB >> 21376929

Factors associated with presence and extent of coronary calcium in those predicted to be at low risk according to Framingham risk score (from the Multi-Ethnic Study of Atherosclerosis).

Tochi M Okwuosa1, Philip Greenland, Susan G Lakoski, Hongyan Ning, Joseph Kang, Roger S Blumenthal, Moyses Szklo, John R Crouse, Joao A C Lima, Kiang Liu, Donald M Lloyd-Jones.   

Abstract

Even among asymptomatic persons at low risk (<10%) according to the Framingham risk score, high coronary artery calcium (CAC) scores signify a greater predicted risk of coronary heart disease events. We sought to determine the noninvasive factors (without radiation exposure) significantly associated with CAC in low-risk, asymptomatic persons. In a cross-sectional analysis, we studied 3,046 participants from the Multi-Ethnic Study of Atherosclerosis at a low 10-year predicted risk (Framingham risk score <10%) of coronary heart disease events. Multivariate logistic regression analysis was used to assess the association of novel markers with the presence of any CAC (CAC >0) and advanced CAC (CAC ≥ 300). A CAC level of >0 and of ≥ 300 was present in 30% and 3.5% of participants, respectively. Factor VIIIc, fibrinogen, and soluble intercellular adhesion molecule were each associated with the presence of CAC (p ≤ 0.02), and C-reactive protein, D-dimer, and the carotid intima-media thickness with advanced CAC (p ≤ 0.03). The base model combining the traditional risk factors had excellent discrimination for advanced CAC (C-statistic 0.808). The addition of the 2 best-fit models combining the biomarkers with or without carotid intima-media thickness improved the c-statistic to 0.822 and 0.820, respectively. All 3 models calibrated well but were similar in estimating the individual risk probabilities for advanced CAC (prevalence 9.97%, 10.63%, and 10.10% in the greatest quartiles of predicted probabilities vs 0.26%, 0.26%, and 0.26% in the lowest quartiles, respectively). In conclusion, in low-risk persons, the traditional risk factors alone predicted advanced CAC with high discrimination and calibration. The biomarker combinations with and without carotid intima-media thickness were also significantly associated with advanced CAC; however, the improvement in the prediction and estimation of the clinical risk were modest compared to the traditional risk factors alone.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21376929      PMCID: PMC3182475          DOI: 10.1016/j.amjcard.2010.10.072

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  24 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  Coronary calcification: insights from sudden coronary death victims.

Authors:  A P Burke; A Taylor; A Farb; G T Malcom; R Virmani
Journal:  Z Kardiol       Date:  2000

Review 3.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.

Authors:  Morteza Naghavi; Peter Libby; Erling Falk; S Ward Casscells; Silvio Litovsky; John Rumberger; Juan Jose Badimon; Christodoulos Stefanadis; Pedro Moreno; Gerard Pasterkamp; Zahi Fayad; Peter H Stone; Sergio Waxman; Paolo Raggi; Mohammad Madjid; Alireza Zarrabi; Allen Burke; Chun Yuan; Peter J Fitzgerald; David S Siscovick; Chris L de Korte; Masanori Aikawa; K E Juhani Airaksinen; Gerd Assmann; Christoph R Becker; James H Chesebro; Andrew Farb; Zorina S Galis; Chris Jackson; Ik-Kyung Jang; Wolfgang Koenig; Robert A Lodder; Keith March; Jasenka Demirovic; Mohamad Navab; Silvia G Priori; Mark D Rekhter; Raymond Bahr; Scott M Grundy; Roxana Mehran; Antonio Colombo; Eric Boerwinkle; Christie Ballantyne; William Insull; Robert S Schwartz; Robert Vogel; Patrick W Serruys; Goran K Hansson; David P Faxon; Sanjay Kaul; Helmut Drexler; Philip Greenland; James E Muller; Renu Virmani; Paul M Ridker; Douglas P Zipes; Prediman K Shah; James T Willerson
Journal:  Circulation       Date:  2003-10-14       Impact factor: 29.690

Review 4.  The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: what is the clinical relevance?

Authors:  Manfredi Rizzo; Ali A Rizvi; Giovam Battista Rini; Kaspar Berneis
Journal:  Acta Diabetol       Date:  2008-10-17       Impact factor: 4.280

5.  The distribution of 10-Year risk for coronary heart disease among US adults: findings from the National Health and Nutrition Examination Survey III.

Authors:  Earl S Ford; Wayne H Giles; Ali H Mokdad
Journal:  J Am Coll Cardiol       Date:  2004-05-19       Impact factor: 24.094

6.  Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals.

Authors:  Philip Greenland; Laurie LaBree; Stanley P Azen; Terence M Doherty; Robert C Detrano
Journal:  JAMA       Date:  2004-01-14       Impact factor: 56.272

7.  Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low- to intermediate-risk adults.

Authors:  George T Kondos; Julie Anne Hoff; Alexander Sevrukov; Martha L Daviglus; Daniel B Garside; Stephen S Devries; Eva V Chomka; Kiang Liu
Journal:  Circulation       Date:  2003-05-12       Impact factor: 29.690

8.  Multi-Ethnic Study of Atherosclerosis: objectives and design.

Authors:  Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy
Journal:  Am J Epidemiol       Date:  2002-11-01       Impact factor: 4.897

Review 9.  Inflammation, the metabolic syndrome and cardiovascular risk.

Authors:  Russell P Tracy
Journal:  Int J Clin Pract Suppl       Date:  2003-03

10.  Estrogen plus progestin and the risk of coronary heart disease.

Authors:  JoAnn E Manson; Judith Hsia; Karen C Johnson; Jacques E Rossouw; Annlouise R Assaf; Norman L Lasser; Maurizio Trevisan; Henry R Black; Susan R Heckbert; Robert Detrano; Ora L Strickland; Nathan D Wong; John R Crouse; Evan Stein; Mary Cushman
Journal:  N Engl J Med       Date:  2003-08-07       Impact factor: 91.245

View more
  4 in total

1.  Prediction of coronary artery calcium progression in individuals with low Framingham Risk Score: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Tochi M Okwuosa; Philip Greenland; Gregory L Burke; John Eng; Mary Cushman; Erin D Michos; Hongyan Ning; Donald M Lloyd-Jones
Journal:  JACC Cardiovasc Imaging       Date:  2012-02

2.  Treatment of patients with intermediate cardiovascular risk: Are clinical measures enough?

Authors:  Alfred A Bove; William P Santamore; Carol Homko; Abul Kashem; Robert Cross; Timothy R McConnell; Gail Shirk; Francis Menapace
Journal:  J Nucl Cardiol       Date:  2011-08-02       Impact factor: 5.952

3.  Coronary artery calcification is inversely related to body morphology in patients with significant coronary artery disease: a three-dimensional intravascular ultrasound study.

Authors:  George D Dangas; Akiko Maehara; Solene M Evrard; Samantha Sartori; Jennifer R Li; Amala P Chirumamilla; Aya Nomura-Kitabayashi; Nilusha Gukathasan; Ahmed Hassanin; Usman Baber; Martin Fahy; Valentin Fuster; Gary S Mintz; Jason C Kovacic
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2013-07-31       Impact factor: 6.875

4.  Vascular calcification, diabetes, and cardiovascular disease: connecting the dots.

Authors:  Jason C Kovacic; Valentin Fuster
Journal:  JACC Cardiovasc Imaging       Date:  2012-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.